All In MedTech

Device Trial Radar · NCT05799950

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

Last checked: Nov 20, 2026Latest source record: Aug 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

138

Actual

Start

Aug 28, 2023

Primary completion

Jun 2, 2025

Study completion Jun 2, 2025

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Apr 5, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes

Summary

As written by the sponsor on the registry.

The purpose of this post-market clinical follow-up (PMCF) study is to describe the long-term safety and performance of AcrySof Single-Piece and AcrySof Multi-Piece monofocal intraocular lenses (IOLs).

Conditions

  • Aphakia

Interventions

  • AcrySof single-piece IOLDevice

    Acrylic single-piece intraocular lens placed in the capsular bag in the posterior chamber of the eye during cataract surgery as a replacement for the natural crystalline lens.

  • AcrySof multi-piece IOLDevice

    Acrylic multi-piece intraocular lens placed in the capsular bag in the posterior chamber of the eye during cataract surgery as a replacement for the natural crystalline lens.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean monocular best corrected distance visual acuity (BCDVA)Time frame: Up to 3 to 5 years post operative
  2. Rate of protocol-specified ocular adverse eventsTime frame: Up to 3 to 5 years post operative

Locations

7 sites in 2 countries. Site status is shown where the registry gives one.

  • Velvet Clinical Research

    Burbank, California

  • Levenson Eye Associates

    Jacksonville, Florida

  • Virdi Eye Clinic

    Rock Island, Illinois

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.